Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Taxol | 0.01 | uM | 4 | 156.25 | 63.10 | 65.00 | 88.50 | 0.7345 | 0.0625 |
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 156.25 | 63.10 | 71.00 | 88.50 | 0.8023 | 0.2733 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 156.25 | 63.10 | 95.00 | 88.50 | 1.0734 | 1.3127 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 156.25 | 63.10 | 78.00 | 88.50 | 0.8814 | 0.5439 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 156.25 | 63.10 | 70.00 | 88.50 | 0.7910 | 0.2368 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 156.25 | 63.10 | 42.00 | 88.50 | 0.4746 | -0.5659 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 91.00 | 88.50 | 1.0282 | 1.1175 | |
| SK-BR-3 | Palbociclib | 1 | uM | 4 | 156.25 | 63.10 | 48.00 | 88.50 | 0.5424 | -0.4292 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 156.25 | 63.10 | 37.00 | 88.50 | 0.4181 | -0.6652 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 80.00 | 88.50 | 0.9040 | 0.6261 | |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 156.25 | 63.10 | 63.00 | 88.50 | 0.7119 | -0.0034 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 156.25 | 63.10 | 95.00 | 88.50 | 1.0734 | 1.3127 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 156.25 | 63.10 | 77.00 | 88.50 | 0.8701 | 0.5036 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 156.25 | 63.10 | 115.00 | 88.50 | 1.2994 | 2.4211 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 156.25 | 63.10 | 90.00 | 88.50 | 1.0169 | 1.0701 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 156.25 | 63.10 | 76.00 | 88.50 | 0.8588 | 0.4639 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 4 | 156.25 | 63.10 | 41.00 | 88.50 | 0.4633 | -0.5868 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 84.00 | 88.50 | 0.9492 | 0.7971 | |
| SK-BR-3 | Palbociclib | 10 | uM | 4 | 156.25 | 63.10 | 72.00 | 88.50 | 0.8136 | 0.3103 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 156.25 | 63.10 | 67.00 | 88.50 | 0.7571 | 0.1306 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 99.00 | 88.50 | 1.1186 | 1.5166 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 51.00 | 88.50 | 0.5763 | -0.3537 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 221.00 | 247.75 | 0.8920 | 0.5600 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 261.00 | 247.75 | 1.0535 | 1.2399 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 312.50 | 180.13 | 213.00 | 247.75 | 0.8597 | 0.4398 |